Matches in SemOpenAlex for { <https://semopenalex.org/work/W2165141131> ?p ?o ?g. }
- W2165141131 endingPage "448.e7" @default.
- W2165141131 startingPage "448.e1" @default.
- W2165141131 abstract "Patients with chronic kidney disease, including kidney transplant recipients, are at high risk for cardiovascular disease (CVD). In addition to the constellation of traditional CVD risk factors in chronic kidney disease, elevated total homocysteine (tHcy) is notably more prevalent among the general population. The Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT) trial is designed to evaluate whether lowering tHcy using vitamin supplementation reduces CVD events in renal transplant recipients. FAVORIT is a multicenter double-blind randomized controlled clinical trial. Participants are clinically stable renal transplant recipients who are 6 months or longer posttransplant with elevated tHcy. Patients are randomized to a multivitamin that includes either a high-dose or low-dose of folic acid (5 or 0 mg), vitamin B6 (50 or 1.4 mg), and vitamin B12 (1000 or 2 μg). The primary end point is a composite of incident or recurrent CVD outcomes, that is, coronary heart, cerebrovascular, or abdominal aortic/lower extremity arterial events. A sample size of 4000 is estimated to provide 87% power to detect a 20% treatment effect. Recruitment is expected to continue until July 2006, with follow-up through June 2010. From August 2002 through December 2004, 2234 of the target 4000 patients were enrolled. In accordance with trial design, mean (SD) screening tHcy was elevated (17.4 ± 6.2 μmol/L), and mean (SD) estimated creatinine clearance was consistent with stable renal function (58.0 ± 18.6 mL/min). Evaluating baseline results to date, 42% of the randomized participants had a history of diabetes mellitus, and 21% had prevalent CVD. The FAVORIT trial is designed with sufficient power and follow-up time to detect a clinically relevant change in CVD risk between renal transplant recipients receiving a high or low tHcy-lowering folic acid multivitamin. Preliminary screening and baseline data support the trial's objectives." @default.
- W2165141131 created "2016-06-24" @default.
- W2165141131 creator A5008205347 @default.
- W2165141131 creator A5015387097 @default.
- W2165141131 creator A5017797625 @default.
- W2165141131 creator A5031560506 @default.
- W2165141131 creator A5032690087 @default.
- W2165141131 creator A5040493032 @default.
- W2165141131 creator A5040913447 @default.
- W2165141131 creator A5064192696 @default.
- W2165141131 date "2006-09-01" @default.
- W2165141131 modified "2023-10-16" @default.
- W2165141131 title "Rationale and design of the Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT) trial" @default.
- W2165141131 cites W1550111394 @default.
- W2165141131 cites W1582000856 @default.
- W2165141131 cites W1902500413 @default.
- W2165141131 cites W1963572183 @default.
- W2165141131 cites W1967300297 @default.
- W2165141131 cites W1983823485 @default.
- W2165141131 cites W1988068836 @default.
- W2165141131 cites W1996233154 @default.
- W2165141131 cites W2014259599 @default.
- W2165141131 cites W2025589168 @default.
- W2165141131 cites W2039880258 @default.
- W2165141131 cites W2043464277 @default.
- W2165141131 cites W2064912482 @default.
- W2165141131 cites W2066523471 @default.
- W2165141131 cites W2100444321 @default.
- W2165141131 cites W2102935853 @default.
- W2165141131 cites W2105066381 @default.
- W2165141131 cites W2113406882 @default.
- W2165141131 cites W2116089455 @default.
- W2165141131 cites W2130956156 @default.
- W2165141131 cites W2147464835 @default.
- W2165141131 cites W2151667576 @default.
- W2165141131 cites W2169871578 @default.
- W2165141131 cites W4231586310 @default.
- W2165141131 cites W4242589154 @default.
- W2165141131 doi "https://doi.org/10.1016/j.ahj.2006.03.004" @default.
- W2165141131 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16923411" @default.
- W2165141131 hasPublicationYear "2006" @default.
- W2165141131 type Work @default.
- W2165141131 sameAs 2165141131 @default.
- W2165141131 citedByCount "57" @default.
- W2165141131 countsByYear W21651411312012 @default.
- W2165141131 countsByYear W21651411312014 @default.
- W2165141131 countsByYear W21651411312015 @default.
- W2165141131 countsByYear W21651411312016 @default.
- W2165141131 countsByYear W21651411312017 @default.
- W2165141131 countsByYear W21651411312018 @default.
- W2165141131 countsByYear W21651411312019 @default.
- W2165141131 countsByYear W21651411312020 @default.
- W2165141131 countsByYear W21651411312021 @default.
- W2165141131 countsByYear W21651411312022 @default.
- W2165141131 crossrefType "journal-article" @default.
- W2165141131 hasAuthorship W2165141131A5008205347 @default.
- W2165141131 hasAuthorship W2165141131A5015387097 @default.
- W2165141131 hasAuthorship W2165141131A5017797625 @default.
- W2165141131 hasAuthorship W2165141131A5031560506 @default.
- W2165141131 hasAuthorship W2165141131A5032690087 @default.
- W2165141131 hasAuthorship W2165141131A5040493032 @default.
- W2165141131 hasAuthorship W2165141131A5040913447 @default.
- W2165141131 hasAuthorship W2165141131A5064192696 @default.
- W2165141131 hasConcept C126322002 @default.
- W2165141131 hasConcept C134018914 @default.
- W2165141131 hasConcept C141071460 @default.
- W2165141131 hasConcept C159641895 @default.
- W2165141131 hasConcept C168563851 @default.
- W2165141131 hasConcept C2776551950 @default.
- W2165141131 hasConcept C2776940978 @default.
- W2165141131 hasConcept C2777090595 @default.
- W2165141131 hasConcept C2778653478 @default.
- W2165141131 hasConcept C2779750884 @default.
- W2165141131 hasConcept C2780303639 @default.
- W2165141131 hasConcept C2908647359 @default.
- W2165141131 hasConcept C2911091166 @default.
- W2165141131 hasConcept C555293320 @default.
- W2165141131 hasConcept C71924100 @default.
- W2165141131 hasConcept C90924648 @default.
- W2165141131 hasConcept C99454951 @default.
- W2165141131 hasConceptScore W2165141131C126322002 @default.
- W2165141131 hasConceptScore W2165141131C134018914 @default.
- W2165141131 hasConceptScore W2165141131C141071460 @default.
- W2165141131 hasConceptScore W2165141131C159641895 @default.
- W2165141131 hasConceptScore W2165141131C168563851 @default.
- W2165141131 hasConceptScore W2165141131C2776551950 @default.
- W2165141131 hasConceptScore W2165141131C2776940978 @default.
- W2165141131 hasConceptScore W2165141131C2777090595 @default.
- W2165141131 hasConceptScore W2165141131C2778653478 @default.
- W2165141131 hasConceptScore W2165141131C2779750884 @default.
- W2165141131 hasConceptScore W2165141131C2780303639 @default.
- W2165141131 hasConceptScore W2165141131C2908647359 @default.
- W2165141131 hasConceptScore W2165141131C2911091166 @default.
- W2165141131 hasConceptScore W2165141131C555293320 @default.
- W2165141131 hasConceptScore W2165141131C71924100 @default.
- W2165141131 hasConceptScore W2165141131C90924648 @default.
- W2165141131 hasConceptScore W2165141131C99454951 @default.
- W2165141131 hasIssue "3" @default.